Delivery Order SPE2DB22D3301-SPE2DB24FX7PU

Award Date 12/22/23
Potential Completion Date 12/26/23
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Feraheme, a 510 mg/17 ml vial medication, with a ceiling value of $7,331. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Feraheme 510 mg/17 ml vials. The contract has a firm fixed-price structure and a ceiling value of $9,635.91. It was awarded on November 4, 2024, with an ultimate completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
The U.S. government has awarded a Firm Fixed Price Delivery Order contract, valued at $1,548.97, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Feraheme 510 mg/17 ml vial medical supplies. This order is placed against an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds as the prime contractor with the Defense Logistics Agency (DLA) Troop Support Medical to deliver a comprehensive range...
This federal contract award is for the delivery of Feraheme 510 mg/17 ml vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $3,764.40, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 27, 2022, with a completion date of January 28, 2022. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is...
This federal contract award is for the delivery of Feraheme 510 mg/17 ml vial, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The $14,952.56 contract was awarded on January 17, 2023 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of January 18, 2023 and is a firm fixed price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $7,547.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, covers the procurement of Feraheme 510 mg/17 ml vials. There was no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Feraheme (ferumoxytol) 510 mg/17 mL vials to the Defense Logistics Agency (DLA). The $3,913.10 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 23, 2021, with an ultimate completion date of August 24, 2021. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
This federal contract award is for the delivery of Feraheme 510 mg/17 ml vials, a pharmaceutical product used in the treatment of iron deficiency anemia. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the total ceiling value is $42,742.37. The contract is not set aside for any specific business type. The award is associated with a larger Indefinite...
This contract, awarded by the Defense Logistics Agency (DLA), is for the delivery of Feraheme (ferumoxytol) injectable medication in 17 mL vials. The contract has a ceiling value of $6,944.12 and runs through October 18, 2024. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
This is a federal delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Feraheme, a medication used to treat iron deficiency anemia, with a ceiling value of $5,347.46. The delivery order has a firm fixed price and an ultimate completion date of August 27, 2024. AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FX7PU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the supply of Feraheme 510 mg/17 ml vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,434.45, and has an ultimate completion date of December 26, 2023.

The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/13/25, 9:55 AM